טוען...
Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies
Objective: To determine the frequency and clinical impact of anticardiolipin antibodies (aCL) in patients with rheumatoid arthritis treated with infliximab and etanercept. Methods: 121 patients from the Stockholm tumour necrosis factor α (TNFα) follow up registry (STURE) treated with infliximab or e...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2004
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1755142/ https://ncbi.nlm.nih.gov/pubmed/15066863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.018093 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|